CERo Therapeutics Holdings, Inc. (OTCQB: CERO) ('CERo' or the 'Company'), an innovative cellular immunotherapy company advancing engineered T cell therapeutics designed to engage phagocytic mechanisms ...
UC Davis is the primary manufacturing site for CER-1236, site activation is expected to expand patient recruitment capacity and streamline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results